Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Living Cell Technologies ( (AU:1AI) ) has provided an announcement.
Algorae Pharmaceuticals Limited has notified the market of the issue of 11 million unquoted options, exercisable at $0.014 and expiring on Dec. 1, 2029, with an issue date of April 2, 2026. These options, designated under ASX security code 1AIAT, form part of a previously announced transaction and are not quoted, nor intended to be quoted, on the ASX, indicating additional incentive or financing structures for stakeholders outside the public trading pool.
The most recent analyst rating on (AU:1AI) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Living Cell Technologies stock, see the AU:1AI Stock Forecast page.
More about Living Cell Technologies
Algorae Pharmaceuticals Limited is an Australian-listed biopharmaceutical company focused on developing pharmaceutical products, as indicated by its ASX issuer code 1AI. The company operates in the life sciences sector and accesses capital markets via both quoted and unquoted securities on the Australian Securities Exchange.
YTD Price Performance: 14.29%
Average Trading Volume: 1,506,343
Technical Sentiment Signal: Hold
Current Market Cap: A$28.18M
For a thorough assessment of 1AI stock, go to TipRanks’ Stock Analysis page.